Health care providers frustrated by intravenous saline shortages said they are encouraged by the possibility that the US government could step in to make pharmaceutical companies establish backup manufacturing facilities.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?